Math and medicine join forces to solve a cancer mystery
Immunotherapy has transformed outcomes for many cancer patients. Unlike conventional treatments, these therapies do not attack tumors directly. Instead, they enable the body's immune system to identify and kill cancer cells that had previously escaped elimination.
A research team from the University of California, Irvine has discovered a mathematical model that could revolutionize the treatment of advanced melanoma, a particularly aggressive form of skin cancer. Conventional treatments, such as immunotherapy, often fail to eradicate tumors entirely, leading to disease recurrence in a significant number of patients.
The model was created by integrating mathematics and biology, allowing the two disciplines to inform each other and enabling researchers to identify the most probable mechanism of resistance. The model was validated against experimental data from mice with melanoma and demonstrated that the rate at which regulatory T cells (Tregs) infiltrated the tumor was a critical distinguishing factor between patients who responded favorably to immunotherapy and those who experienced disease recurrence.
By engineering mice with inefficient Treg migration into the tumor, the team was able to confirm this prediction experimentally, showing that the combination of PD-1 blockade immunotherapy and reduced Treg infiltration substantially improved survival duration and slowed tumor growth. This innovative approach offers a faster, more cost-efficient method for determining which therapeutic strategies are most likely to succeed, potentially saving time and resources in cancer research.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
